Succinylcholine Chloride Injection — Class II drug recall D-0008-2026
Ongoing recall by Dr. Reddy's Laboratories, Inc., reported 2025-10-15, distributed nationwide. Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.
| Recall number | D-0008-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Dr. Reddy's Laboratories, Inc., Princeton, NJ, United States |
| Recall initiated | 2025-09-26 |
| Classified | 2025-10-07 |
| Reported by FDA | 2025-10-15 |
| Distributed | Nationwide (US) |
| Quantity | 571 vials |
| Reason classes | specification failure |
| NDC | 43598-0666, 43598-0666-11, 43598-0666-25 |
| Lot numbers | K250048 |
Product
Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials, For Intravenous or Intramuscular use, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540. NDC: 43598-666-25
Reason for recall
Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0008-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.